Liver Transplantation Pathology

On this page

Indications & Pre-Tx Eval - Liver Lifeline Launch

  • Indications:
    • Acute Liver Failure (ALF): e.g., viral, drug-induced.
    • Chronic Liver Disease (CLD): Decompensated (ascites, varices, encephalopathy); MELD > 15.
    • Hepatocellular Carcinoma (HCC): Within Milan Criteria.
    • Metabolic: Wilson's, A1AT deficiency.
    • Cholestatic (end-stage): PSC, PBC.
  • Pre-Tx Evaluation:
    • Severity: MELD/PELD score.
      • 📌 MELD: Bilirubin, Creatinine, INR.
    • HCC Staging: Milan Criteria (1 lesion ≤5cm; or ≤3 lesions, each ≤3cm; no major vascular/extrahepatic spread).
    • Contraindications: Active sepsis/extrahepatic malignancy, severe cardiorespiratory disease, active substance abuse.
    • Workup: Cardiac, pulmonary, renal, infectious, psychosocial.

⭐ MELD score (Bilirubin, Creatinine, INR) is key to predict 3-month mortality in cirrhosis & prioritize transplant.

Milan criteria for HCC liver transplant

Graft Types & Immunosuppression - Organ Offers & Immune Ops

  • Graft Types:

    • Deceased Donor (DDLT): Whole, split, reduced-size.
    • Living Donor (LDLT): Right lobe (adults), left lateral (children).
  • Immunosuppression:

    • Phases: Induction, Maintenance, Rejection treatment.
    • Key Drugs:
      ClassDrugsMoA (Key)Key SE (Path)
      CNIsTacrolimus, Cyclosporine↓IL-2, ↓T-cell act.Nephro/Neurotoxicity
      AntimetabolitesMMF, AZA↓Lymph. prolif.BM suppression, GI (MMF)
      mTOR inh.Sirolimus, EverolimusBlock IL-2 signal, ↓T prolifDelayed healing, Ulcers
      SteroidsPrednisoneBroad anti-inflam.Hyperglycemia, ↑Infection
  • Immune Ops: ABO compatibility essential. HLA matching beneficial. Crossmatch vital.

⭐ Tacrolimus, a common calcineurin inhibitor, is notorious for causing nephrotoxicity and neurotoxicity.

Rejection Pathology - Graft's Immune Gauntlet

TypeTimingMechanismKey Histo FeaturesKey Banff (ACR: V,B,E)
HyperacuteMins-hrsPre-formed Ab (ABO)Thrombosis, fibrinoid necrosis, PMNsN/A
ACRDays-wks (<3mo)T-cell mediatedVenous endotheliitis (V), Bile duct damage (B), Portal inflammation (E)V,B,E criteria met
AMRDays-wks (late)DSA (anti-HLA), C4d+Capillaritis, C4d deposition, microvascular inflammation (MVI)C4d+, MVI, DSA+
ChronicMonths-yrsMixed; fibrosisVanishing bile duct syndrome (VBDS), obliterative arteriopathyDuctopenia, fibrosis

⭐ Classic ACR triad (Banff V,B,E criteria): Venous endothelialitis (V), Bile duct injury (B), and Portal inflammation (E). At least two components usually needed for diagnosis.

Acute cellular rejection in liver transplant

Non-Rejection Complications - Post-Op Perils & Pathogens

  • Vascular: Hepatic Artery Thrombosis (HAT) (early, common), Portal Vein Thrombosis (PVT).
  • Biliary: Leaks (early), Strictures (anastomotic/ischemic, later).
  • Infections: See table & timeline. Key examples:
    • CMV: "Owl's eye" inclusions.

    • EBV (PTLD): Atypical lymphoid infiltrates.

    • Aspergillus: Angioinvasion, septate hyphae. Aspergillus hyphae in liver tissue (PAS, GMS)

  • Disease Recurrence: HCV, HBV, HCC, PSC.
  • Drug Toxicity: CNI nephrotoxicity.

⭐ HAT: most common vascular issue, risks graft loss. CMV: key opportunistic pathogen (1-6 mo).

Common Post-Transplant Infections

PathogenTimingKey Pathology
Bacteria<1 moAbscesses, cholangitis
Candida spp.<1 moMicroabscesses
CMV1-6 mo"Owl's eye" inclusions, hepatitis
EBV (PTLD)1-6 mo+Atypical lymphoid infiltrates
Aspergillus spp.1-6 moAngioinvasion, necrosis

High-Yield Points - ⚡ Biggest Takeaways

  • Hyperacute rejection: Minutes-hours, preformed anti-donor antibodies (ABO/HLA), irreversible graft damage.
  • Acute cellular rejection (ACR): Most common (days-weeks), T-cell mediated; triad: endotheliitis, bile duct injury, eosinophils. Responds to immunosuppression.
  • Chronic rejection: Months-years, ductopenic (vanishing bile duct syndrome) or vascular (obliterative arteriopathy), leads to graft loss.
  • PTLD: EBV-driven B-cell proliferation; risk with high immunosuppression.
  • Recurrence of primary disease (HCV, HCC) is a major concern.
  • Opportunistic infections (CMV, fungal) are key complications.

Practice Questions: Liver Transplantation Pathology

Test your understanding with these related questions

Which of the following statements regarding rejection of solid organ transplants is true?

1 of 5

Flashcards: Liver Transplantation Pathology

1/10

Budd-chiari syndrome will lead to _____nodular cirrhosis

TAP TO REVEAL ANSWER

Budd-chiari syndrome will lead to _____nodular cirrhosis

micro

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial